Exicure
is an Illinois-based biotechnology company that researches and develops nucleic acid therapies for the treatment of neurological disorders... Read moreExicure
is an Illinois-based biotechnology company that researches and develops nucleic acid therapies for the treatment of neurological disorders... Read more
News
Jun 30, 2026
GlobeNewswire
Press Release: Exicure : Exicure Announces Board and Committee Changes
May 29, 2026
Benzinga
Exicure: Exicure Q1 EPS $(0.29) Down From $0.49 YoY
Apr 23, 2026
Nasdaq
Exicure: Exicure To Co-develop Burixafor With Adbiotech For Multiple Indications
Mar 27, 2026
Owler
Exicure, Inc.: Exicure's employee count changed from 7 in Dec 2024 to 8 in Dec 2025
Mar 26, 2026
Seeking Alpha
Exicure: Exicure GAAP EPS of -$0.79
Mar 25, 2026
Benzinga
Exicure: Exicure Q4 EPS $(0.22) Up From $(3.39) YoY.
Mar 25, 2026
GlobeNewswire
Press Release: Exicure : Exicure, Inc. Reports Full Year 2025 Financial Results
Feb 05, 2026
GlobalNewswire
Press Release: Exicure : Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant
Jan 21, 2026
Benzinga
Exicure: Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
Dec 09, 2025
Nasdaq
Exicure: Exicure Soars On Burixafor Data In Multiple Myeloma Trial
Exicure Competitors
1
2
3
4
5
6
7
8
9
10